Your Account
Filter Articles
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Project Updates
- Stakeholder Events
- Uncategorized
- Young People with MS
More than 21,000 people call for action on ocrelizumab for Primary Progressive MS in the UK
08.03.2019
More than 21,000 people have signed a petition launched by the MS Society UK, calling for ocrelizumab to be made…
After 20 years, the “Is MS Treatment Still a Lottery?” campaign has achieved its objective in Croatia
08.03.2019
The Croatian MS Society presented new guidelines for Multiple Sclerosis (MS) treatment which, after 20 years, will finally provide timely…
21st State of Art Symposium around the challenges of MS treatment in Switzerland
08.03.2019
Paediatric MS and MS in old age were the two main topics neurologists explored at the 21st State of the…
Increased number of monthly physiotherapy sessions for people with MS in Greece
08.03.2019
Thanks to the continuous effort of the Hellenic Federation of Persons with MS, the Greek National Health Care Provider (EOPYY)…
EMSP 2019 Roundtable Discussion & Networking Dinner
08.03.2019
On the 25 February, at Hotel Crowne Plaza, in Brussels, Belgium we took a fresh approach to the EMSP Annual…
MS Nurse PRO launch event in Greece
08.03.2019
The Hellenic Federation of People with MS, in partnership with the Greek MS Society (GMSS), have translated six modules of…
